{
  "id": 3596838,
  "title": "Stock Market Today, Aug. 26: Boston Scientific Shares Fall 5% on Cybersecurity Incident and Product Recall",
  "url": "https://urgent.news/2026/08/26/stock-market-today-aug-26-boston-scientific-shares-fall-5-on",
  "topic": "finance",
  "section": "Finance & Markets",
  "published": "2026-08-26T21:11:38.000Z",
  "source": {
    "name": "Motley Fool",
    "slug": "motley-fool",
    "url": "https://www.fool.com/coverage/stock-market-today/2026/08/26/stock-market-today-aug-26-boston-scientific-shares-fall-5-on-cybersecurity-incident-and-product-recall/?source=iedfolrf0000001"
  },
  "original_language": "en",
  "account": "Boston Scientific, a global medical device maker, experienced a 5% drop in its shares on August 26, 2023, following a cybersecurity incident and a product recall. The company's stock closed at $48.17, down 3.38% from the previous close. Pre-market reports indicated that the cyberattack disrupted global operations and shipping activities. In addition to the cybersecurity incident, Boston Scientific announced a recall of certain types of its percutaneous catheters, which further contributed to the stock's decline. Investors are closely monitoring the company's ability to restore its systems and assess the impact of the recall on the ongoing disruption. Trading volume for Boston Scientific reached 31.8 million shares, approximately 48% higher than its three-month average of 21.4 million shares. The S&P 500 (SNPINDEX:^GSPC) experienced a slight decline of 0.04% to 7,675, while the Nasdaq Composite (NASDAQINDEX:^IXIC) saw a marginal drop of 0.08% to 26,130. Among peers in the medical devices and interventional medtech sectors, Abbott Laboratories (NYSE:ABT) saw its shares dip by 1.75% to $114.10, while Medtronic (NYSE:MDT) ended the day up 0.95% at $92.01, as the cyber disruption at Boston Scientific stood out as the primary concern. Over the past year, Boston Scientific's stock has been on a downward trajectory, dropping by 55%. The combination of the cybersecurity incident and the product recall, tied to the company's ENROUTE Transcarotid Neuroprotection System (NPS), has exacerbated investor concerns. The FDA had expressed reservations regarding the potential separation of the product's arterial sheath tip, which led to the recall.",
  "summary": "On Aug. 26, 2026, a cyberattack halted order processing and shipping at the medical device maker, leaving investors uncertain about the speed of recovery and near-term shipment delays.",
  "key_points": [],
  "editors_take": null,
  "illustration": null,
  "coverage": {
    "outlets": 2,
    "also_reported_by": [
      {
        "outlet": "Nasdaq Markets",
        "title": "Stock Market Today, Aug. 26: Boston Scientific Shares Fall 5% on Cybersecurity Incident and Product Recall",
        "url": "https://urgent.news/2026/08/26/stock-market-today-aug-26-boston-scientific-shares-fall-5-on-3598423",
        "published": "2026-08-26T21:31:38.000Z"
      }
    ]
  },
  "ai_generated": true,
  "disclaimer": "Summaries, key points and the editor’s take are written by software from other outlets’ reporting and may contain errors — always check the linked original."
}